Fair point - I assume the choice of the word 'rapid' is used in this case to signify results that are out of the ordinary.
Hopefully these sorts of results start to sway those at the FDA with respect to Rem-L's ability to demonstrate treatment effect as they certainly had some doubts in the GvHD briefing papers.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-53
-
- There are more pages in this discussion • 371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.005(0.43%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.828M | 1.560M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 18409 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32450 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 63079 | 1.170 |
16 | 61793 | 1.165 |
15 | 103947 | 1.160 |
16 | 160071 | 1.155 |
18 | 600805 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 3126 | 4 |
1.180 | 106742 | 13 |
1.185 | 98273 | 12 |
1.190 | 169722 | 15 |
1.195 | 58421 | 6 |
Last trade - 12.07pm 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online